NH TherAguix is a French biotech start-up developing innovative nanomedicine that enhance radiation therapy benefits without modifying current clinical workflows. Our leading product, AGuIX® is a nanoparticle designed to improve the localization of solid tumors and the outcomes of radiation therapy by intravenous injection. The company is pursuing its strategy ambitiously as it is currently focused on its clinical development (end of Phase 2) in Europe and in the USA.
To support our growth, we are recruiting a Junior Scientist for our Research & Discovery Department.
For more information: